Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
checkpoint inhibitors
Biotech
Scancell enjoys stock bounce on back of cancer vaccine data
It’s been a good week for Scancell, as investors appeared to seized on early data from a phase 2 cancer vaccine trial to send its stock up 20%.
James Waldron
Sep 19, 2023 10:55am
KRAS inhibitor, immunotherapy halts pancreatic cancer in mice
Aug 29, 2023 9:56am
ASCO: Novocure's electric fields extend lung cancer survival
Jun 6, 2023 8:00am
Gilead and Arcus' TIGIT combo continues to show signs of life
Jun 3, 2023 1:30pm
BioNTech's $200M bet on next-gen Yervoy triggers tumor responses
Jun 2, 2023 10:00am
PD-1 R&D tapers off as new molecules capture interest: IQVIA
May 24, 2023 2:09pm
